Dossier
cytokine release syndrome
Coverage of cytokine release syndrome in the Nexus archive.
- London startup to trial drug to prevent cancer therapy side-effect ‘cytokine storm’
London-based startup Poolbeg Pharma is trialing POLB 001 at six NHS hospitals to prevent cytokine release syndrome in cancer patients undergoing immunotherapy. The company is also developing a GLP-1 weight loss pill.